Physician profile
Michael Gilbert Levin
NPI 1548622277
$1,474.88
in general payments reported to CMS, 2019-2025
7 companies · $1,094 in 2025
The $1,094 reported for 2025 was more than what a typical Cardiovascular Disease provider received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $61.30 · 2020: $16.47 · 2021: $57.37 · 2022: $73.96 · 2023: $172 · 2025: $1,094.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $1,094 · Food and Beverage: $172.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $1,093.75 |
| Food and Beverage | $172.03 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bridgebio Pharma, INC. | $1,093.75 | 2025 | Attruby |
| Merck Sharp & Dohme LLC | $98.64 | 2023 | Verquvo |
| Novartis Pharmaceuticals Corporation | $73.96 | 2022 | |
| Aurinia Pharma U.S., INC. | $73.39 | 2023 | Lupkynis |
| Boston Scientific Corporation | $47.63 | 2019-2020 | |
| Horizon Therapeutics Plc | $44.37 | 2021 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $43.14 | 2019-2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Levin listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.